1515
Annons
Elicera Therapeutics announces participation in several industry and investor meetings in October and November

Gothenburg, October 5, 2021 - Elicera Therapeutics AB (publ), a clinical stage cell and gene therapy company that develops immunooncological treatments focusing on CAR T-cells and oncolytic viruses, announced today that the company will attend the following industry and investor meetings in October and November 2021:

  • ESGCT (European Society of Gene & Cell Therapy) Virtual Congress 2021 - 19-21 oktober 2021
Associate Professor Di Yu, Development Manager at Elicera Therapeutics, will present preclinical data for the company's iTANK platform.
  • 13th Annual PEGS Europe Summit (Protein & Antibody Engineering Summit) - 2-4 november 2021
Professor Magnus Essand, Chief Scientific Officer at Elicera Therapeutics, will present preclinical data for the company's iTANK platform.
  • Investival showcase 2021 - 8-15 november
Jamal El-Mosleh, CEO of Elicera Therapeutics, will attend individual meetings with potential partners and investors.
  • Stora Aktiedagen Göteborg - 9 november
Jamal El-Mosleh, CEO of Elicera Therapeutics, will give a company presentation.
  • Aktieportföljen Live - 24 november
Jamal El-Mosleh, CEO of Elicera Therapeutics, will give a company presentation.
  • Stora Aktiedagen Stockholm - 29 november

Jamal El-Mosleh, CEO of Elicera Therapeutics, will give a company presentation.

Source: Cision
Tillbaka

Det verkar som att du använder en annonsblockerare

Om du är prenumerant behöver du logga in för att fortsätta. Vill bli prenumerant kan du läsa Di Digitalt för 197 kr inkl. moms de första 3 månaderna.

spara
1090kr
Prenumerera